LISA BABB: Open Payments
NPI 1043568652 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 17 payments from 9 companies in 2025. Trend: 2023 $181 · 2024 $450 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 3 | $68 |
| Tris Pharma Inc | 3 | $67 |
| Corium, LLC | 2 | $43 |
| ABBVIE INC. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: Jornay PM, Dyanavel XR, Azstarys, VRAYLAR, Auvelity, SPRAVATO, Quviviq, REXULTI.
Industry payments across FL — which companies pay providers there.
